Effective treatment of immune system: A Synthesis of Findings from 15 Studies

  1. Home
  2. Effective treatment of immune system
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effective treatment of immune system: A Synthesis of Findings from 15 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effective treatment of immune system: A Synthesis of Findings from 15 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Key Research Findings

Several research papers highlight the significant impact of the immune system on cancer metastasis, development, and treatment efficacy. For example, a study ( 1 ) found that mannose-binding lectin-associated serine protease-2 (MASP-2) and the neutrophil-to-lymphocyte ratio (NLR) are associated with cervical cancer metastasis. Another research ( 2 ) suggests that retinoid X receptor (RXR) agonists can modulate the tumor microenvironment by controlling both inflammation and immune responses, potentially leading to new cancer treatments. Additionally, a study ( 10 ) demonstrated that a live biotherapeutic, Lactococcus lactis GEN3013, enhances cancer treatment efficacy by regulating cancer progression and the immune system.

These studies suggest that modulating the immune system holds promise for cancer treatment, potentially through various drug therapies and lifestyle modifications. For instance, a research ( 13 ) indicates that complement inhibitors and kallikrein inhibitors could be promising treatments for COVID-19-associated acute respiratory distress syndrome (ARDS). Another study ( 5 ) suggests that nanoparticle-based targeting of immune cells could enhance the effectiveness of cancer immunotherapy.

Treatment Summary

A study ( 2 ) suggests that retinoid X receptor (RXR) agonists could offer a new treatment approach for cancer. RXR plays a crucial role in regulating key signaling pathways that influence cancer cell growth and immune responses. RXR agonists could potentially benefit cancer treatment by suppressing inflammation or activating immune cells. Currently, Bexarotene, an RXR agonist, is approved for treating cutaneous T-cell lymphoma. Further research is underway to develop other RXR agonists for potential use in treating various types of cancer.

Research ( 10 ) highlights a live biotherapeutic, Lactococcus lactis GEN3013, as a potential enhancer of cancer treatment efficacy. This bacterial strain can modulate cancer progression and the immune system to improve treatment outcomes. Specifically, Lactococcus lactis GEN3013 can inhibit tumor growth by suppressing tumor angiogenesis and directly inducing cancer cell death. Additionally, this strain has been shown to enhance the efficacy of cancer treatment drugs such as oxaliplatin and PD-1 inhibitors.

Benefits and Risks

Benefits Summary

Modulating the immune system can potentially suppress cancer metastasis, enhance treatment efficacy, and improve overall patient outcomes.

Risks Summary

Immunosuppressant medications can increase the risk of infections. Additionally, immunotherapies might trigger autoimmune diseases. It's crucial to consult with a healthcare professional and understand the potential risks and benefits before undergoing any treatment.

Research Comparison

Research Similarities

Multiple research papers indicate that the immune system plays a crucial role in cancer metastasis, development, and treatment response. There's a general agreement that modulating the immune system can improve cancer treatment outcomes.

Research Differences

Each research study utilizes different methods for immune system modulation and focuses on specific cancer types. For example, a study ( 1 ) investigates the role of MASP-2 and NLR in cervical cancer metastasis. In contrast, another study ( 2 ) explores the potential of RXR agonists in treating various cancers.

Consistency and Contradictions in Findings

While several studies suggest that immune system modulation can benefit cancer treatment, the methods and cancer types investigated vary, making direct comparisons challenging. Future research should delve deeper into the immune system's role across diverse cancer types and treatment approaches.

Real-life Application Considerations

The immune system is complex and varies among individuals, so treatment approaches may not be universally effective. Immunotherapies can also have side effects. Consulting with a healthcare professional to discuss potential risks and benefits is crucial before starting any treatment.

Limitations of Current Research

Although current studies highlight the potential of immune system modulation in cancer treatment, specific mechanisms and effective treatment methods remain to be fully understood. Further research is needed to unravel detailed mechanisms and develop safe and effective treatment strategies.

Future Research Directions

Future research should aim to further investigate how immune system modulation can impact cancer treatment. Developing safer and more effective immunotherapies is essential. Research efforts should also focus on identifying biomarkers that can determine the effectiveness of immunotherapies for specific cancer types and patients.

Conclusion

The immune system significantly influences cancer metastasis, development, and treatment response. Modulating the immune system offers a promising avenue to improve cancer treatment outcomes. Further research into safer and more effective immunotherapies holds potential to provide hope for countless cancer patients.

Treatment List

  • Retinoid X receptor (RXR) agonists
  • Live biotherapeutic (Lactococcus lactis GEN3013)
  • Complement inhibitors
  • Kallikrein inhibitors
  • Nanoparticle-based immune cell targeting
Literature analysis of 15 papers
Positive Content
13
Neutral Content
1
Negative Content
1
Article Type
0
0
1
8
14
1.

Pre-treatment inflammatory and immune system parameters predicting cervical cancer metastasis.

Author: AvishaMirah, PelupessyNugraha Utama, RahmanAbdul, RaufSyahrul, RakhmahNur, HamidFirdaus

Cervical cancer metastasis

Pretreatment MASP-2 levels and neutrophil lymphocyte ratio (NLR) were associated with cervical cancer metastasis. NLR is a simple and cost-effective indicator that can be used in clinical practice.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

2.

Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer.

Author: LealAna S, HungPei-Yu, ChowdhuryAfrin Sultana, LibyKaren T

Cancer prevention
Cancer treatment

This review explores the role of retinoid X receptors (RXR) in regulating inflammation and tumor immunity. The study discusses how RXR agonists can modulate the tumor microenvironment by influencing both inflammation and immune responses. The review highlights the potential of RXR-dependent immune cell modulation as a therapeutic strategy for cancer treatment and prevention.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

4.

Immune system roles in pathogenesis, prognosis, control, and treatment of Toxoplasma gondii infection.

Author: JafariMohammad Mahdi, Azimzadeh TabriziZahra, DayerMohammad Saaid, Kazemi-SefatNazanin Atieh, MohtashamifardMahshid, MohseniRahimeh, BagheriAtefeh, BahadorySaeed, Karimipour-SaryazdiAmir, GhaffarifarFatemeh

Immunotherapy
Prognosis marker

This review explores the immunopathogenesis, prognosis, and immunotherapy of Toxoplasma gondii infection, highlighting the role of the immune system in the disease and the potential of immunotherapy for treatment.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

8.

Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model.

Author: Berg-LarsenAxel, MobergslienAnne, MoenIngrid, PetrosGebregziabher, KristianAlexander, GunvaldsenKristine Sponheim, CrucianiVéronique, WickstroemKatrine, BjerkeRoger Malerbakken, KarlssonJenny, CuthbertsonAlan

TAT immune activation
TAT immune protection
TAT tumor growth inhibition

This research demonstrates the immune activation and long-lasting protection of targeted alpha therapy (TAT) using a thorium-labeled antibody in a syngeneic model, highlighting the potential of combining TAT with checkpoint inhibition therapy.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Language : English

9.

Etiopathogenesis, Diagnosis, and Treatment Strategies for Lymphomatoid Papulosis with Particular Emphasis on the Role of the Immune System.

Author: NowickaDanuta, MertowskaPaulina, MertowskiSebastian, HymosAnna, FormaAlicja, MichalskiAdam, MorawskaIzabela, HrynkiewiczRafał, Niedźwiedzka-RystwejPaulina, GrywalskaEwelina

Misdiagnosis
Progression to lymphoma

This article discusses lymphomatoid papulosis (LyP), a rare skin disease. It explores the clinical and histopathological features, diagnostic criteria, and treatment strategies for LyP. The authors highlight the importance of early diagnosis and appropriate treatment to prevent progression to lymphoma.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

11.

Possible mechanism for improving the endogenous immune system through the blockade of peripheral μ-opioid receptors by treatment with naldemedine.

Author: GondohEizoh, HamadaYusuke, MoriTomohisa, IwazawaYusuke, ShinoharaAsami, NaritaMichiko, SatoDaisuke, TezukaHiroyuki, YamauchiTakayasu, TsujimuraMayu, YoshidaSara, TanakaKenichi, YamashitaKensuke, AkatoriHaruka, HigashiyamaKimio, ArakawaKazuhiko, SudaYukari, MiyanoKanako, IsekiMasako, InadaEiichi, KuzumakiNaoko, NaritaMinoru

Improved immune function
Tumor regression

Systemic administration of the peripheral μ-opioid receptor (MOR) antagonist naldemedine significantly decreased tumor volume and prolonged survival in tumor-bearing mice. Naldemedine may induce an anti-tumor effect by recovering T-cell exhaustion and promoting the tumor-killing system.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

13.

How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment.

Author: NilssonBo, PerssonBarbro, ErikssonOskar, FromellKarin, HultströmMichael, FrithiofRobert, LipcseyMiklos, Huber-LangMarkus, EkdahlKristina N

COVID-19 treatment

COVID-19 can lead to serious complications like blood clotting and lung inflammation. This review discusses the role of the intravascular innate immune system (IIIS) in COVID-19 pathogenesis and explores potential therapies that target specific components of the IIIS to improve patient outcomes.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

14.

Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy.

Author: MancusoSalvatrice, MattanaMarta, CarlisiMelania, SantoroMarco, SiragusaSergio

Adoptive immunotherapy
Chemo-free regimens
Passive immunotherapy

B-cell lymphoma is a type of cancer that affects the immune system. This review examines how different therapies for B-cell lymphoma impact the immune system, focusing on the development of new treatment approaches that target the immune system.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

15.

The interaction between nanoparticles and immune system: application in the treatment of inflammatory diseases.

Author: LiuJin, LiuZeyang, PangYan, ZhouHuifang

Immunomodulation
Inflammation treatment
Long-term effects
Security concerns

This review explores the potential of nanoparticles as immunomodulators in the treatment of inflammatory diseases. Nanoparticles can interact with various components of the immune system, offering new possibilities for managing immune-related conditions. However, further research is needed to understand the long-term effects and ensure safety.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.